| Contents |
Management of nausea and vomiting in cancer treatment: introduction, scope of the problem -- Mechanisms of acute, delayed, and anticipatory emesis induced by anticancer therapies -- Methodological issues in the assessment of nausea and vomiting -- The role of prognostic factors in chemotheraphy-induced nausea and vomiting -- Impact of nausea and vomiting on health-related quality of life -- A biobehavioral perspective of nausea and emesis -- Integrated therapy of nausea and vomiting -- Serotonin-receptor antagonists -- Persistent problems in emesis control -- Radiation-induced emesis -- Substance P antagonists -- Futher improvement in the control of chemotherapy-induced nausea and vomiting: future directions |
